# Detection of Lipoarabinomannan in Urine Evaluation of the STANDARDTMF TBLAMFIA and Its Impact on the Initial TB Diagnosis

> **NCT06306430** · — · NOT_YET_RECRUITING · sponsor: **Ospedale San Raffaele** · enrollment: 550 (estimated)

## Conditions studied

- Tuberculosis
- Diagnoses Disease

## Interventions

- **DEVICE:** STANDARDTM F TB LAM FIA

## Key facts

- **NCT ID:** NCT06306430
- **Lead sponsor:** Ospedale San Raffaele
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-10
- **Primary completion:** 2024-10
- **Final completion:** 2025-10
- **Target enrollment:** 550 (ESTIMATED)
- **Last updated:** 2024-09-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06306430

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06306430, "Detection of Lipoarabinomannan in Urine Evaluation of the STANDARDTMF TBLAMFIA and Its Impact on the Initial TB Diagnosis". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT06306430. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*